News & Analysis as of

Samsung Bioepis Biocon

Goodwin

Biosimilar Market Update - Biocon Biologics LTD and Samsung Bioepis

Goodwin on

Last week, Biocon Ltd announced the approval of approximately a 150 million USD capital injunction from Goldman Sachs. Dr. Christian Hamacher, CEO, Biocon Biologics, said, “This capital injection by Goldman Sachs will enable...more

1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide